Antonia Bouts
Overview
Explore the profile of Antonia Bouts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cambier A, Dossier C, Lapeyraque A, Phan V, Laroche C, Abukasm K, et al.
Pediatr Nephrol
. 2025 Jan;
PMID: 39779508
No abstract available.
2.
Zurowska A, Drozynska-Duklas M, Topaloglu R, Bouts A, Boyer O, Shenoy M, et al.
Pediatr Nephrol
. 2024 Dec;
40(3):877-878.
PMID: 39699592
No abstract available.
3.
Bokenkamp A, Bouts A, van der Weerd N, Levtchenko E, Haffner D, Zivicnjak M
Pediatr Nephrol
. 2024 Sep;
40(3):701-703.
PMID: 39292251
Schimke immuno-osseous-dysplasia (SIOD) is an autosomal recessive systemic disease due to pathogenic variants in SMARCAL1. Manifestations include nephrotic syndrome (NS), kidney failure, T-cell dysfunction, vaso-occlusive disease, and disproportionate short stature,...
4.
Assfalg V, Miller G, Stocker F, Huser N, Hartmann D, Heemann U, et al.
Transplantation
. 2023 Dec;
108(5):1200-1211.
PMID: 38073036
Background: Whenever the kidney standard allocation (SA) algorithms according to the Eurotransplant (ET) Kidney Allocation System or the Eurotransplant Senior Program fail, rescue allocation (RA) is initiated. There are 2...
5.
Zurowska A, Drozynska-Duklas M, Topaloglu R, Bouts A, Boyer O, Shenoy M, et al.
Pediatr Nephrol
. 2023 Apr;
38(9):3035-3042.
PMID: 37014530
Background: There is paucity of information on rituximab-associated hypogammaglobulinemia (HGG) and its potential infectious consequences in children treated for idiopathic nephrotic syndrome (INS). Methods: A survey was distributed by the...
6.
Patry C, Sauer L, Sander A, Krupka K, Fichtner A, Brezinski J, et al.
Pediatr Nephrol
. 2022 Oct;
38(5):1621-1632.
PMID: 36264431
Background: Randomized controlled trials in pediatric kidney transplantation are hampered by low incidence and prevalence of kidney failure in children. Real-World Data from patient registries could facilitate the conduct of...
7.
Tourlamain G, Keijzer-Veen M, Bouts A, Cransberg K, de Jong H, De Pauw R, et al.
Pediatr Nephrol
. 2022 Apr;
38(1):279-289.
PMID: 35482097
Background: Catch-up growth after pediatric kidney transplantation (kTx) is usually insufficient to reach normal adult height. We aimed to analyze the effect of pre-transplant recombinant human growth hormone (rhGH) and...
8.
Assfalg V, Miller G, Stocker F, van Meel M, Groenevelt T, Tieken I, et al.
Transplantation
. 2021 Oct;
106(6):1215-1226.
PMID: 34608103
Background: At Eurotransplant (ET), kidneys are transferred to "rescue allocation" (RA), whenever the standard allocation (SA) algorithms Eurotransplant Kidney Allocation System (ETKAS) and Eurotransplant Senior Program (ESP) fail. We analyzed...
9.
Weber L, Tonshoff B, Grenda R, Bouts A, Topaloglu R, Gulhan B, et al.
Pediatr Transplant
. 2020 Dec;
25(3):e13955.
PMID: 33378587
Recurrence of primary disease is one of the major risks for allograft loss after pediatric RTx. The risk of recurrence of FSGS/SRNS after pediatric RTx in particular can be up...
10.
Vanderstraeten K, De Pauw R, Knops N, Bouts A, Cransberg K, El Amouri A, et al.
Pediatr Nephrol
. 2020 Oct;
36(4):977-986.
PMID: 33034742
Background: Hyperparathyroidism persists in up to 50% of pediatric kidney transplant recipients. The aims of this study were to describe the evolution of parathyroid hormone (PTH) in the first year...